Related references
Note: Only part of the references are listed.The differential expression of IL-4 and IL-13 and its impact on type-2 immunity
Katherine Bao et al.
CYTOKINE (2015)
Anrukinzumab, an anti-interleukin 13 monoclonal antibody, in active UC: efficacy and safety from a phase IIa randomised multicentre study
Walter Reinisch et al.
GUT (2015)
Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis
Marc E. Rothenberg et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Development of an ultra-sensitive single molecule counting assay for the detection of interleukin-13 as a marker for asthmatic severity
Boyenoh Gaye et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2015)
Changes of the cytokine profile in inflammatory bowel diseases
Gyoergyi Muzes et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Effects of Interleukin-13 Blockade on Allergen-induced Airway Responses in Mild Atopic Asthma
Gail M. Gauvreau et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
IL-13 Antibodies Influence IL-13 Clearance in Humans by Modulating Scavenger Activity of IL-13Rα2
Marion T. Kasaian et al.
JOURNAL OF IMMUNOLOGY (2011)
High Affinity, Developability and Functional Size: The Holy Grail of Combinatorial Antibody Library Generation
Dirk Ponsel et al.
MOLECULES (2011)
Recombinant antibody libraries and selection technologies
Heyue Zhou et al.
NEW BIOTECHNOLOGY (2011)
Clinical and Correlative Results of SWOG S0354: A Phase II Trial of CNTO328 (Siltuximab), a Monoclonal Antibody against Interleukin-6, in Chemotherapy-Pretreated Patients with Castration-Resistant Prostate Cancer
Tanya B. Dorff et al.
CLINICAL CANCER RESEARCH (2010)
Population Pharmacokinetics of Therapeutic Monoclonal Antibodies
Nathanael L. Dirks et al.
CLINICAL PHARMACOKINETICS (2010)
Comparative pharmacokinetics of single-dose administration of mammalian and bacterially-derived recombinant human granulocyte-macrophage colony-stimulating factor
Doris Hovgaard et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Analytical validation of a highly sensitive microparticle-based immunoassay for the quantitation of IL-13 in human serum using the Erenna® immunoassay system
Katie St Ledger et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2009)
IL-13 as a therapeutic target for respiratory disease
Marion T. Kasaian et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Efficacy of IL-13 neutralization in a sheep model of experimental asthma
Marion T. Kasaian et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2007)
FcRn: the neonatal Fc receptor comes of age
Derry C. Roopenian et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Latest technologies for the enhancement of antibody affinity
Kim L. Wark et al.
ADVANCED DRUG DELIVERY REVIEWS (2006)
A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis
Jasper J. Haringman et al.
ARTHRITIS AND RHEUMATISM (2006)
IL-13 receptors and signaling pathways: An evolving web
GKK Hershey
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
Share Paper
